VINEETLAB.BO

Basic Materials Chemicals

Vineet Laboratories Limited

₹37.41
+1.04 +2.86% today

Price History

Not enough data

Key Stats

Market Cap
718.51M
Avg Volume
33,476
P/E (TTM)
37.41
EPS
₹1.00
52W High
₹51.84
52W Low
₹28.00
Div. Yield
0.0%

Valuation

P/B Ratio
2.45
P/S Ratio
1.21
EV/EBITDA
10.62
EV/Revenue
1.53

Margins

Gross Margin 35.1%
Operating Margin 10.5%
Net Margin 1.9%
EBITDA Margin 14.4%

Growth & Returns

Revenue Growth (YoY)
22.6%
Return on Equity
3.7%
Return on Assets
3.5%

Liquidity & Leverage

Current Ratio
1.47
Quick Ratio
0.42
Debt / Equity
0.99
Total Cash
170.75M
Total Debt
453.25M

About

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

vineetlabs.co.in